Today's signals · No active technical signal.
Signal details →Travere Therapeutics last closed at $57.67 (+1.30%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -124.0×. Its overall grade ranks 508 of 741 stocks in Healthcare.
About this company
Travere Therapeutics last closed at $57.67 (+1.30%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 508/741
Valuation grade F
Related stocks
- NovartisCompetitor
희귀질환·신장질환 치료제 시장에서 경쟁
- RocheCompetitor
신장질환·면역질환 치료제 개발 경쟁
- AstraZenecaCompetitor
희귀질환 및 신장 관련 치료제 파이프라인 경쟁
ETFs holding this stock
Innovator IBD Breakout Opportunities ETF · Invesco Dynamic Pharmaceuticals ETF · Innovator IBD 50 ETF
Details →About Travere Therapeutics
- What technical signals does Travere Therapeutics (TVTX) have?
- Travere Therapeutics current technical signals: no active technical signal.
- Is Travere Therapeutics a cup-and-handle pattern?
- No. Travere Therapeutics has no valid Cup signal right now.
- What published figures are available for Travere Therapeutics?
- Market cap: $5.16B. Trailing 12 months PER: -124.0×. Latest quarter PBR: 219.84×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Travere Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.